Stemolecule Wnt Inhibitor IWP-3

Cat# 04-0035

Size : 2mg

Brand : ReproCELL

Contact local distributor :


Phone : +1 850 650 7790

Stemolecule™ Wnt Inhibitor IWP-3

04-0035

Brand: Stemolecule

Wnt Inhibitor IWP-3 prevents palmitylation of Wnt proteins by Porcupine (Porcn), a membrane-bound O-acyltransferase, thereby blocking Wnt secretion and activity.

CAS Number: 687561-60-0
Alternate Name(s):
  • 2-(3-(4-fluorophenyl)-3,4,6,7-tetrahydro-4-oxothieno[3,2-d]pyrimidin-2-ylthio)-N-(6-methylbenzo[d]thiazol-2-yl)acetamide

Note: shown do not include shipping and handling charges.

Product Information

Stemolecule Wnt Inhibitor IWP-3 was identified in a high throughput screen for antagonists of the Wnt/β-catenin pathway. Wnt Inhibitor IWP-3 prevents palmitylation of Wnt proteins by Porcupine (Porcn), a membrane-bound O-acyltransferase, thereby blocking Wnt secretion and activity. It also blocks phosphorylation of the Lrp6 receptor and accumulation of both Dvl2 and β-catenin1. The inhibition of the Wnt pathway through the use of IWP-3 has also been shown to promote the formation of cardiomyocytes from human embryonic stem cell-derived mesoderm cells2.


04-0035 Specifications Sheet

Safety Data Sheets:

Chen, B., Dodge, M.E., Tang, W., Lu, J., Ma, Z., Fan, C.W., Wei, S., Hao, W., Kilgore, J., Williams, N.S., Roth, M.G., Amatruda, J.F., Chen, C., and Lum, L. Small molecule-mediated disruption of Wnt-dependent signaling in tissue regeneration and cancer. Nat Chem Biol 5: 100-107 (2009).
  • Willems, E., Spiering, S., Davidovics, H., Lanier, M., Xia, Z., Dawson, M., Cashman, J., and Mercola, M. Small-molecule inhibitors of the Wnt pathway potently promote cardiomyocytes from human embryonic stem cell-derived mesoderm. Circ Res 109: 360-364 (2011).
  • Additional Publications

    • Kitano Y; Nishimura S; Kato TM; Ueda A; Takigawa K; Umekaga M; Nomura M; Kawakami A; Ogawa H; Xu H; Hotta A; Takasu N; Tsukahara M. Generation of hypoimmunogenic induced pluripotent stem cells by CRISPR-Cas9 system and detailed evaluation for clinical application. Molecular Therap: Methods Clinical Develop 26:15 (2022).
    • Tsujisaka T; Hatani T; Okubo C; Ito R; Kimura A; Narita M; Chonabayashi K ;Funakoshi S; Lucena-Cacace A; Toyoda T; Osafune K; Kimura T; Saito H; Yoshida Y.. Purification of human iPSC-derived cells at large scale using microRNA switch and magnetic-activated cell sorting. Stem Cell Rep 17:1772 (2022).
    • Okamoto R; Goto I; Nishimura Y; Kobayashi I; Hashizume R; Yoshida Y; Ito R; Kobayashi Y; Nishikawa M; Ali Y; Saito S; Tanaka T; Sawa Y; Ito M; Dohi K. Gap junction protein beta 4 plays an important role in cardiac function in humans, rodents, and zebrafish. PLos One :240129 (2020).
    • Matsura K; Wada M; Sakaguchi K; Matsuhashi Y; Shimizu T. Adequate taylor couette flow-mediated shear stress is useful for dissociating human iPS cell-derived cell aggregates. Regen Therap in press:https://doi.org/10.1016/j.reth.2019.04.006 (2019).
    • Ito E; Miyagawa S; Takeda A; Kawamura A; Harada A; Iseoka H; Yajima S; Sougawa N; Michizuki-Oda N; Yasuda S; Sato Y; Sawa Y. Tumorigenicity assay essential for facilitating safety studies of hiPSC-derived cardiomyocytes for clinical application. Sci Rep 9:1881 (2019).
    • Lee H; Haller C; Manneville C; Doll T; Fruh I; Gubser Keller C; Richards SM; Ibig-Rehm Y; Patoor M; Goette M; Bouchez LC; Mueller M. Identification of Small Molecules Which Induce Skeletal Muscle Differentiation in Embryonic Stem Cells via Activation of the Wnt and Inhibition of Smad2/3 and Sonic Hedgehog Pathways. Stem Cells 34:299-310 (2016).
    • Funakoshi S; Miki K; Takaki T; Okubo C; hatani T; Chonabayashi K; Nishikawa M; Takei I; Oishi A; Narita M; Hoshijima M; Kimura T; Yamanaka S; Yoshida Y. Enhanced engraftment, proliferation, and therapeutic potential in heart using optimized human iPSC-derived cardiomyocytes. Sci Rep 6:19111 (2016).
    • Cheesboro J. Mechanism of segmentation in the American cockroach, Perplaneta americana. Ph.D. Thesis, University of Sussex (2012).